Klaus Schmierer
Klaus Schmierer
Blizard Institute, Barts and The London School of Medicine // Barts Health NHS Trust
Email verificata su qmul.ac.uk - Home page
Titolo
Citata da
Citata da
Anno
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
K Schmierer, F Scaravilli, DR Altmann, GJ Barker, DH Miller
Annals of neurology 56 (3), 407-415, 2004
6582004
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
L Kappos, R Gold, DH Miller, DG MacManus, E Havrdova, V Limmroth, ...
The Lancet 372 (9648), 1463-1472, 2008
5292008
Association between pathological and MRI findings in multiple sclerosis
M Filippi, W Brück, D Chard, F Fazekas, JJG Geurts, C Enzinger, ...
The Lancet Neurology 18 (2), 198-210, 2019
3792019
Diffusion tensor imaging of post mortem multiple sclerosis brain
K Schmierer, CAM Wheeler-Kingshott, PA Boulby, F Scaravilli, ...
Neuroimage 35 (2), 467-477, 2007
3642007
No cerebrocervical venous congestion in patients with multiple sclerosis
F Doepp, F Paul, JM Valdueza, K Schmierer, SJ Schreiber
Annals of neurology 68 (2), 173-183, 2010
3632010
High field MRI correlates of myelin content and axonal density in multiple sclerosis
JP Mottershead, K Schmierer, M Clemence, JS Thornton, F Scaravilli, ...
Journal of neurology 250 (11), 1293-1301, 2003
2552003
Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation
K Schmierer, CAM Wheeler‐Kingshott, DJ Tozer, PA Boulby, HG Parkes, ...
Magnetic Resonance in Medicine: An Official Journal of the International …, 2008
2502008
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain
K Schmierer, DJ Tozer, F Scaravilli, DR Altmann, GJ Barker, PS Tofts, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007
2352007
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
G Giovannoni, B Turner, S Gnanapavan, C Offiah, K Schmierer, M Marta
Multiple sclerosis and related disorders 4 (4), 329-333, 2015
2242015
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI
RA Farrell, D Antony, GR Wall, DA Clark, L Fisniku, J Swanton, Z Khaleeli, ...
Neurology 73 (1), 32-38, 2009
1932009
A review of structural magnetic resonance neuroimaging
M Symms, HR Jäger, K Schmierer, TA Yousry
Journal of Neurology, Neurosurgery & Psychiatry 75 (9), 1235-1244, 2004
1562004
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study
AD Goodman, H Rossman, A Bar-Or, A Miller, DH Miller, K Schmierer, ...
Neurology 72 (9), 806-812, 2009
1512009
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
R Raftopoulos, SJ Hickman, A Toosy, B Sharrack, S Mallik, D Paling, ...
The Lancet Neurology 15 (3), 259-269, 2016
1472016
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis
K Schmierer, HG Parkes, PW So, SF An, S Brandner, RJ Ordidge, ...
Brain 133 (3), 858-867, 2010
1432010
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
N Scolding, D Barnes, S Cader, J Chataway, A Chaudhuri, A Coles, ...
Practical neurology 15 (4), 273-279, 2015
1402015
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis
C Dobson-Stone, A Danek, L Rampoldi, RJ Hardie, RM Chalmers, ...
European Journal of Human Genetics 10 (11), 773-781, 2002
1372002
Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis
D Baker, M Marta, G Pryce, G Giovannoni, K Schmierer
EBioMedicine 16, 41-50, 2017
1182017
Interpreting lymphocyte reconstitution data from the pivotal phase 3 trials of alemtuzumab
D Baker, SS Herrod, C Alvarez-Gonzalez, G Giovannoni, K Schmierer
JAMA neurology 74 (8), 961-969, 2017
1062017
Assessment of normal flow velocity in basal cerebral veins: a transcranial Doppler ultrasound study
JM Valdueza, K Schmierer, S Mehraein, KM Einhaüpl
Stroke 27 (7), 1221-1225, 1996
991996
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
J Pakpoor, G Disanto, DR Altmann, S Pavitt, BP Turner, M Marta, ...
Neurology-Neuroimmunology Neuroinflammation 2 (6), 2015
912015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20